Table 3.
Antibiotics | All age groups | < 5 years | ≥ 5 years | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Diarrhea n = 127 n (%) | Control n = 9 n (%) | χ 2 | P value | Diarrhea n = 93 n (%) | Control n = 5 n (%) | χ 2 | P value | Diarrhea n = 34 n (%) | Control n = 4 n (%) | χ 2 | P value | |
AMP | 100 (78.74) | 8 (88.89) | – | 0.294* | 78 (83.87) | 5 (100.00) | – | 0.428* | 22 (64.71) | 3 (75.00) | – | 0.405* |
AMC | 47 (37.01) | 4 (44.44) | – | 0.245* | 33 (35.48) | 1 (20.00) | – | 0.318* | 14 (41.18) | 3 (75.00) | – | 0.194* |
CEP | 38 (29.92) | 4 (44.44) | – | 0.184* | 33 (35.48) | 2 (40.00) | – | 0.348* | 5 (14.71) | 2 (50.00) | – | 0.132* |
CTX | 23 (18.11) | 3 (33.33) | – | 0.166* | 21 (22.58) | 2 (40.00) | – | 0.252* | 2 (5.88) | 1 (25.00) | – | 0.266* |
GEN | 39 (30.71) | 5 (55.56) | – | 0.091* | 29 (31.18) | 3 (60.00) | – | 0.157* | 10 (29.41) | 2 (50.00) | – | 0.291* |
NAL | 65 (51.18) | 6 (66.67) | – | 0.187* | 52 (55.91) | 3 (60.00) | – | 0.349* | 13 (38.24) | 3 (75.00) | – | 0.167* |
CIP | 7 (5.51) | 3 (33.33) | – | 0.018* | 6 (6.45) | 0 (0.00) | – | 0.724* | 1 (2.94) | 3 (75.00) | – | 0.002* |
TCY | 88 (69.29) | 5 (55.56) | – | 0.192* | 64 (68.82) | 3 (60.00) | – | 0.328* | 24 (70.59) | 2 (50.00) | – | 0.291* |
REP | 124 (97.64) | 9 (100.00) | – | 0.813* | 91 (97.85) | 5 (100.00) | – | 0.900* | 33 (97.06) | 4 (100.00) | – | 0.895* |
SXT | 79 (62.20) | 5 (55.56) | – | 0.250* | 62 (66.67) | 2 (40.00) | – | 0.178* | 17 (50.00) | 3 (75.00) | – | 0.278* |
Notes: 1: AMP Ampicillin, AMCAmoxicillin and Clavulafiate, CEP Cephalothin, CTX Cefotaxime, GEN Gentamicin, NAL Nalidixic acid, CIP Ciprofloxacin, TCY Tetracycline, REP Rifampicin, SXT Sulfamethoxazole–Trimethoprim
2: The “–” means that the data cannot be calculated, the “*” means that the data was calculated with Fisher exact
3: The bold was showed there had significant difference between two groups